#United States #Berkeley Heights #pharmaceuticals #Breckenridge #Maiva Pharma

Breckenridge Pharmaceutical Forms Strategic Partnership with Maiva Pharma

Breckenridge Pharmaceutical, Inc., the U.S. arm of Towa International, has recently announced a significant strategic partnership with Maiva Pharma Pvt. Ltd. This collaboration is aimed at enhancing the supply of sterile injectable products specifically for hospitals and clinics across the United States.

Strengthening Market Position

This partnership significantly strengthens Breckenridge's status as a dependable supplier within the U.S. hospital market. Maiva will act as a critical manufacturing ally for various injectable products, thereby expanding the capacity of Breckenridge to provide essential medications to healthcare facilities.

Brian Guy, who holds the position of President and Chief Commercial Officer at Breckenridge, emphasized the importance of this partnership. He stated, "Ensuring consistent access to critical care injectables is key for our mission and for the needs of the U.S. hospital community." The partnership not only enhances their reliability in the hospital channel but also aligns with Breckenridge's commitment to broaden patient access to high-quality, affordable medicines.

Three-Faceted Business Model

This initiative also represents a pivotal moment for Breckenridge as it evolves into three clearly defined healthcare channels: specialty, hospital, and retail. This restructuring allows the company to better cater to patient needs while offering healthcare providers effective and economical treatment options.

Breckenridge is now on a mission to expand its footprint within the pharmaceutical supply chain for hospitals. By collaborating with Maiva, renowned for its expertise in sterile injectable manufacturing, Breckenridge is poised to boost its operational capacity and assure the availability of critical medications to hospitals nationwide.

About Breckenridge Pharmaceutical

Breckenridge Pharmaceutical, located in New Jersey, operates as the U.S. subsidiary of Towa International, based in Barcelona, Spain. The company collaborates with manufacturers across the nation and around the globe to deliver quality and cost-effective generic pharmaceuticals to American patients. Their dedication to customer service, timely deliveries, and reliable supply plays a crucial role in their business philosophy aimed at uplifting the health of the patients they serve.

To learn more about Breckenridge’s offerings, visit www.breckenridgepharma.com.

About Maiva Pharma Pvt. Ltd.

Maiva Pharma stands as a leading manufacturer of sterile injectables, supplying over 45 products to the U.S. market. With more than three decades of experience in sterile manufacturing, the company has established a strong reputation for providing high-quality, reliable injectable solutions to global pharmaceutical entities. Maiva operates two state-of-the-art facilities located near Bengaluru, India, employing around 1,200 skilled professionals. Their expansive sterile capabilities include liquid, lyophilized, and suspension injectables in vials and IV bags, with recent expansions into prefilled syringes and cartridge systems. By focusing on quality, compliance, and operational efficiency, Maiva Pharma continues to solidify its status as a trusted partner in the healthcare industry.

In conclusion, this strategic partnership showcases the commitment of both Breckenridge Pharmaceutical and Maiva Pharma to improving patient care by ensuring availability and access to essential injectable medications in the U.S. healthcare system.